MSB 11.8% $1.57 mesoblast limited

Cell Therapy News/Articles, page-18281

  1. 1,929 Posts.
    lightbulb Created with Sketch. 214
    Yeah would have to read up on it, my formal science is decades old. I do get the impression that the apoptosis and local + systemic clearance provides confidence of reduced negative affects vis a vis uncontrolled pluripotent growth subsequent to anti inflammatory effects mediated through downstream cell changes.
    Maybe that will be part of a future in vitro potency assay matrix but demonstrated in vitro trilineage pluripotency is seldom manifest in vivo from what I've learnt at the Sandstone University of Youtube etc.
    Maybe NP + disc volume positive effects is just mediated via ECM augmentation in an intercellular modulatory mechanism - nice to imagine a future in vivo chondrogenesis role with a robust correlated in vitro potency assay for MSB product though.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.210(11.8%)
Mkt cap ! $1.838B
Open High Low Value Volume
$1.72 $1.74 $1.52 $15.63M 9.716M

Buyers (Bids)

No. Vol. Price($)
1 5127 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.57 59183 5
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.